Literature DB >> 28675695

Predictors of treatment response to psychological interventions in people at clinical high risk of first-episode psychosis.

Helen Wessels1, Michael Wagner2, Kathrin Kuhr3, Julia Berning2, Verena Pützfeld1, Birgit Janssen4, Ronald Bottlender5, Kurt Maurer6, Hans-Jürgen Möller7, Wolfgang Gaebel4, Heinz Häfner6, Wolfgang Maier2, Joachim Klosterkötter1, Andreas Bechdolf1,8.   

Abstract

AIM: Psychological interventions, such as cognitive behavioural therapy (CBT) and supportive counselling (SC), are used to treat people with schizophrenia and people at clinical high risk (CHR) of psychosis. However, little information is available on predictors of treatment response. This study aims to identify such predictors of psychological interventions in CHR.
METHODS: A total of 128 help-seeking CHR outpatients were randomized into two groups-integrated psychological intervention (IPI), including CBT, and SC-for 12 months. Multiple regression analysis was used to identify demographic, symptomatic and functional variables that predict improvement in positive (PANSS Positive), negative (PANSS Negative) and basic symptoms (Basic symptom total score) and improvement in functioning (GAF) at 1-year follow up.
RESULTS: In the merged group (IPI + SC), people who lived independently, were younger and presented with higher baseline functioning showed more improvement in symptomatic outcomes at follow up. Negative symptoms at baseline predicted less improvement in positive and basic symptoms. Being married or cohabiting and living in the primary family were found to correlate with good functioning at 1-year follow up.
CONCLUSIONS: Younger CHR individuals and those who are functioning well may particularly benefit from early intervention. Treatment might need to be modified for low-functioning CHR and those who already display higher scores of negative symptoms. Registration number: NCT00204087.
© 2017 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  clinical high risk; early intervention; predictors; schizophrenia; treatment response

Mesh:

Year:  2017        PMID: 28675695     DOI: 10.1111/eip.12460

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.732


  1 in total

1.  Chronic N-Acetylcysteine Treatment Prevents Amphetamine-Induced Hyperactivity in Heterozygous Disc1 Mutant Mice, a Putative Prodromal Schizophrenia Animal Model.

Authors:  Chuan-Ching Lai; Rathinasamy Baskaran; Chih-Yu Tsao; Li-Heng Tuan; Pei-Fen Siow; Mahalakshmi Palani; Lukas Jyuhn-Hsiarn Lee; Chih-Min Liu; Hai-Gwo Hwu; Li-Jen Lee
Journal:  Int J Mol Sci       Date:  2022-08-20       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.